Date Filed | Type | Description |
04/07/2021 |
GN
| Aleafia Health Launches Everyday Cannabis Brand Divvy |
03/25/2021 |
GN
| Aleafia Health Reports 2020 Year End Results, Record Quarterly Revenue |
03/16/2021 |
GN
| Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market |
03/09/2021 |
GN
| Aleafia Health Announces Closing of $22.7 Million Bought Deal Offering |
02/17/2021 |
GN
| Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million |
02/16/2021 |
GN
| Aleafia Health Announces $15 Million Bought Deal Offering of Units |
02/02/2021 |
GN
| Aleafia Health Repays $25M Debt with Cash, Provides Update on Sales Growth, New Product Mix |
02/01/2021 |
GN
| Aleafia Health to Appoint Two New Independent Directors |
01/29/2021 |
GN
| Aleafia Health Announces Change to Board of Directors |
01/21/2021 |
GN
| Unifor and Aleafia Health enter exclusive agreement to support medical cannabis coverage for members |
01/12/2021 |
GN
| Aleafia Health Launches Portfolio of Exclusive Cultivars |
01/08/2021 |
GN
| Aleafia Health Enters Definitive Supply Agreement with European Pharmaceutical Producer Apipharm |
12/15/2020 |
GN
| Aleafia Health Enters Supply Agreement with Cannabis Brand House BLLRDR |
12/10/2020 |
GN
| Aleafia Health to Enter Israeli Cannabis Market, Bolstering International Sales Opportunity |
11/11/2020 |
GN
| Aleafia Health Announces Third Quarter 2020 Results |
11/06/2020 |
GN
| Aleafia Health Successful Outdoor Harvest Accelerates Product Portfolio Expansion |
09/01/2020 |
GN
| Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany |
08/21/2020 |
GN
| Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer |
08/12/2020 |
GN
| Aleafia Health Announces Second Quarter 2020 Results |
07/24/2020 |
GN
| Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO® |
06/30/2020 |
GN
| Aleafia Health Announces Election of Directors |
06/25/2020 |
GN
| Aleafia Health Inc. and Emblem Cannabis Corporation Announce Settlement of Claim |
06/08/2020 |
GN
| Aleafia Health to Commence Cultivation in Entire 160,000 sq. ft. Niagara Greenhouse Facility |
05/29/2020 |
GN
| Aleafia Health Announces Closing of $14.95 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option |
05/27/2020 |
GN
| Aleafia Health Announces TSX Ticker Symbol Change to AH |
07/25/2007 |
8-K
| Quarterly results |
07/18/2007 |
8-K
| Other Events |
07/17/2007 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
07/13/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
07/05/2007 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/03/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
07/02/2007 |
SC 13D
| Noonday Asset Management, L.P. reports a 5.2% stake in Armor Holdings, Inc. |
06/26/2007 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
06/21/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|